2023
DOI: 10.1007/s00415-023-11813-z
|View full text |Cite
|
Sign up to set email alerts
|

Magnetic resonance neurography and diffusion tensor imaging of the sciatic nerve in hereditary transthyretin amyloidosis polyneuropathy

Roberto Gasparotti,
Alessandro Salvalaggio,
Daniele Corbo
et al.

Abstract: The therapeutic advance in hereditary transthyretin amyloidosis (ATTRv amyloidosis) requires quantitative biomarkers of nerve involvement in order to foster early diagnosis and monitor therapy response. We aimed at quantitatively assessing Magnetic Resonance Neurography (MRN) and Diffusion Tensor Imaging (DTI) properties of the sciatic nerve in subjects with ATTRv-amyloidosis-polyneuropathy (ATTRv-PN) and pre-symptomatic carriers (ATTRv-C). Twenty subjects with pathogenic variants of the TTR gene (mean age 62.… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 54 publications
0
2
0
Order By: Relevance
“…In clinical Vignette #2, MR neurography showed alterations of the sciatic nerve related to the presence of amyloid deposits between the fascicles with associated signs of muscle denervation in a patient with peripheral neuropathy hereditary transthyretin amyloidosis [23][24][25].…”
Section: Discussionmentioning
confidence: 99%
“…In clinical Vignette #2, MR neurography showed alterations of the sciatic nerve related to the presence of amyloid deposits between the fascicles with associated signs of muscle denervation in a patient with peripheral neuropathy hereditary transthyretin amyloidosis [23][24][25].…”
Section: Discussionmentioning
confidence: 99%
“…Recently, ATTRv-PN was differentiated from ATTRv pre-symptomatic carriers and healthy controls by using MRN and DTI of the sciatic nerve ( 98 ). The method was also able to detect subclinical changes in asymptomatic carriers, thereby facilitating early diagnosis and evaluation of progression ( 99 ).…”
Section: From Clinical Features To Diagnostic Approachmentioning
confidence: 99%